Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportEndocrine/Neuroendocrine Cancers

Predictive factors of post-operative thyroglobulin <0.2 ng/ml and pre-ablation stimulated thyroglobulin > 10 ng/ml in differentiated thyroid carcinoma

Hongxi Wang and Rong Tian
Journal of Nuclear Medicine August 2022, 63 (supplement 2) 2988;
Hongxi Wang
1West China Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rong Tian
1West China Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

2988

Introduction: To identify predictive factors of post-operative thyroglobulin (Tg) <0.2 ng/ml and pre-ablation stimulated Tg (s-Tg) > 10 ng/ml in differentiated thyroid carcinoma (DTC) patients.

Methods: Data from DTC patients with post-operative Tg <0.2 ng/ml and negative anti-Tg antibody (TgAb) and received radioiodine (RAI) ablation in our tertiary center between January 2009 and January 2019 were retrospectively analyzed. Independent and non-paired Student's t-test and Mann-Whitney U test were employed for continuous variables. For categorical variables, a Pearson's Chi-square test or Fisher's exact test were performed. The cut-off values of continuous variables were determined using receiver operating characteristic (ROC) curve. Variables in univariate analysis were included in the multivariate logistic regression analysis. All analyses were 2-tailed tests based on &alpha; = 0.05 and R version 3.4.0 were used for data analysis (http://www.R-project.org).

Results: Out of 1152 DTC patient with post-operative Tg <0.2 ng/ml and negative anti-Tg antibody (TgAb), 162 (14.1%) patients' s-Tg were more than 10 ng/ml and 990 (85.9%) patients' s-Tg were no more than 10 ng/ml. The gender, tumor size, lymph node ratio (LNR), stage, ATA risk stratification, hypertension, and drinking history were significantly different between two groups (P<0.05). The best cut-off value of age, tumor size and LNR was 36 years, 19.5mm, and 32.9%, respectively. In multivariate logistic regression, only tumor size >19.5mm (OR=3.2, 95%CI: 1.7-4.6, P<0.01) and LNR >32.9% (OR=4.16, 95%CI: 2.3-7.8, P<0.01) were associated with s-Tg>10 ng/ml. After a median follow-up of 4.7 years, structural recurrence was diagnosed in 19 patients with s-Tg no more than 10 ng/ml and 11 patients >10 ng/ml, respectively. No difference was found between two groups in structural recurrence (p>0.05). Additionally, we compared s-Tg level and structural recurrence according to ATA risk stratification, two hundred, 626 and 245 of 1152 patients were low-, intermediate-, and high-risk. 7.5% (n=15), 12.1% (n=76), and 17.6% (n=43) patients with s-Tg >10 ng/ml in three risk stratification group. Structural recurrence was diagnosed in 13.3% (n=2), 5.3% (n=4), and 11.6% (n=5) patients in three risk stratification groups of patients with s-Tg>10 ng/ml. And structural recurrence was diagnosed in 1.6% (n=3), 1.8% (n=10), and 3.0% (n=6) patients in three risk stratification groups of patients with s-Tg

Conclusions: A large proportion of DTC patients with post-operative Tg <0.2 ng/ml and negative anti-Tg antibody (TgAb) are likely to present with s-Tg > 10 ng/ml, which indicating a poorer outcome. Tumor size >19.5mm and LNR >32.9% were predictors of s-Tg>10 ng/ml in those patients.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 63, Issue supplement 2
August 1, 2022
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Predictive factors of post-operative thyroglobulin 10 ng/ml in differentiated thyroid carcinoma
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Predictive factors of post-operative thyroglobulin <0.2 ng/ml and pre-ablation stimulated thyroglobulin > 10 ng/ml in differentiated thyroid carcinoma
Hongxi Wang, Rong Tian
Journal of Nuclear Medicine Aug 2022, 63 (supplement 2) 2988;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Predictive factors of post-operative thyroglobulin <0.2 ng/ml and pre-ablation stimulated thyroglobulin > 10 ng/ml in differentiated thyroid carcinoma
Hongxi Wang, Rong Tian
Journal of Nuclear Medicine Aug 2022, 63 (supplement 2) 2988;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Correlation between BRAFV600E mutation and 131I uptake capacity of pulmonary metastases in differentiated thyroid cancer
  • Utility of 68Ga-DOTANOC PET/CT in culprit lesion localisation in rare entity like Tumor Induced Osteomalacia.
Show more Endocrine/Neuroendocrine Cancers

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire